GLASF Quote, Financials, Valuation and Earnings

Electromed, Inc. has a net margin of -31.7% compared to Glass House Brands, Inc.'s net margin of 12.65%. Glass House Brands, Inc.'s return on equity of -0.75% beat Electromed, Inc.'s return on equity of 18.89%.

Glass House Brands, Inc. has a consensus price target of $10.17, signalling upside risk potential of 59.03%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 29.45%. Given that Glass House Brands, Inc. has higher upside potential than Electromed, Inc., analysts believe Glass House Brands, Inc. is more attractive than Electromed, Inc..

Glass House Brands, Inc. has a beta of 0.412, which suggesting that the stock is 58.804% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.

Glass House Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glass House Brands, Inc. pays -1074.75% of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

Glass House Brands, Inc. quarterly revenues are $38.4M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. Glass House Brands, Inc.'s net income of -$12.2M is lower than Electromed, Inc.'s net income of $2.1M. Notably, Glass House Brands, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 29.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glass House Brands, Inc. is 3.53x versus 3.71x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Myomo, Inc. has a net margin of -31.7% compared to Glass House Brands, Inc.'s net margin of -36.3%. Glass House Brands, Inc.'s return on equity of -0.75% beat Myomo, Inc.'s return on equity of -68.35%.

Glass House Brands, Inc. has a consensus price target of $10.17, signalling upside risk potential of 59.03%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 380.77%. Given that Myomo, Inc. has higher upside potential than Glass House Brands, Inc., analysts believe Myomo, Inc. is more attractive than Glass House Brands, Inc..

Glass House Brands, Inc. has a beta of 0.412, which suggesting that the stock is 58.804% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.

Glass House Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glass House Brands, Inc. pays -1074.75% of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.

Glass House Brands, Inc. quarterly revenues are $38.4M, which are larger than Myomo, Inc. quarterly revenues of $10.1M. Glass House Brands, Inc.'s net income of -$12.2M is lower than Myomo, Inc.'s net income of -$3.7M. Notably, Glass House Brands, Inc.'s price-to-earnings ratio is -- while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glass House Brands, Inc. is 3.53x versus 1.02x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -31.7% compared to Glass House Brands, Inc.'s net margin of -862.39%. Glass House Brands, Inc.'s return on equity of -0.75% beat VolitionRX Ltd.'s return on equity of --.

Glass House Brands, Inc. has a consensus price target of $10.17, signalling upside risk potential of 59.03%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than Glass House Brands, Inc., analysts believe VolitionRX Ltd. is more attractive than Glass House Brands, Inc..

Glass House Brands, Inc. has a beta of 0.412, which suggesting that the stock is 58.804% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Glass House Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glass House Brands, Inc. pays -1074.75% of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Glass House Brands, Inc. quarterly revenues are $38.4M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Glass House Brands, Inc.'s net income of -$12.2M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Glass House Brands, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glass House Brands, Inc. is 3.53x versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -31.7% compared to Glass House Brands, Inc.'s net margin of 3.93%. Glass House Brands, Inc.'s return on equity of -0.75% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Glass House Brands, Inc. has a consensus price target of $10.17, signalling upside risk potential of 59.03%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Glass House Brands, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Glass House Brands, Inc..

Glass House Brands, Inc. has a beta of 0.412, which suggesting that the stock is 58.804% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Glass House Brands, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Glass House Brands, Inc. pays -1074.75% of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Glass House Brands, Inc. quarterly revenues are $38.4M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Glass House Brands, Inc.'s net income of -$12.2M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Glass House Brands, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Glass House Brands, Inc. is 3.53x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.